The Ig heavy chain (IgH) constant region (C H ) genes are organized from 5 to 3 in the order C, C␦, C␥3, C␥1, C␥2b, C␥2a, C, and C␣. Expression of C H genes downstream of C␦ involves class-switch recombination (CSR), a process that is targeted by germ-line transcription (GT) of the corresponding C H gene. Previously, we demonstrated that insertion of a PGK-neo r cassette at two sites downstream of C␣ inhibits, in cultured B cells, GT of and CSR to a subset of C H genes (including C␥3, C␥2a, C␥2b, and C) that lie as far as 120 kb upstream. Here we show that insertion of the PGK-neo r cassette in place of sequences in the I␥2b locus inhibits GT of and CSR to the upstream C␥3 gene, but has no major effect on the downstream C␥2a and C genes. Moreover, replacement of the C exons with a PGK-neo r cassette in the opposite transcriptional orientation also inhibits, in culture, GT of and CSR to the upstream C␥3, C␥2b, and C␥2a genes. As with the PGK-neo r insertions 3 of C␣ studied previously, the C␥1 and C␣ genes were less affected by these mutations both in culture and in mice, whereas the C␥2b gene appeared less affected in vivo. Our findings support the existence of a long-range 3 IgH regulatory region required for GT of and CSR to multiple C H genes and suggest that PGK-neo r cassette insertion into the locus short circuits the ability of this region to facilitate GT of dependent C H genes upstream of the insertion.
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Ig variable regions are encoded by component gene segments that are assembled during early B cell differentiation by V(D)J recombination (reviewed in ref. 1) . The IgH locus contains eight different constant region (C H ) genes organized as follows: 5Ј V(D)J-C-C␦-C␥3-C␥1-C␥2b-C␥2a-C-C␣-3Ј (Fig. 1) . Newly differentiated B lymphocytes produce complexes of heavy chains and Ig light chains referred to as IgM. Subsequently, mature B cells can change the class of Ig produced from IgM to IgG, IgE, or IgA through a second specific genomic rearrangement process termed heavy chain class-switch recombination (CSR). CSR results in the generation of a new transcription unit containing the same productively rearranged V(D)J exon together with the new downstream C H exons (1, 2) , accompanied by deletion of intervening DNA sequences. CSR involves recombination between large, repetitive sequences called switch (S) regions located upstream of individual C H genes (reviewed in ref. 3 ).
CSR to particular C H genes is directed by different combinations of activators and lymphokines (reviewed in refs. 4 and 5) via their ability to modulate germ-line transcription (GT) of a given C H gene before CSR (2) . For example, stimulation of B cells with bacterial lipopolysaccharide (LPS) induces GT of and CSR to C␥2b and C␥3, whereas inclusion of interleukin 4 (IL-4) with the LPS treatment inhibits GT of and CSR to C␥2b and C␥3 while inducing GT of and CSR to C␥1 and C (1, 3, 5) . In the context of a given form of activation, other lymphokines can induce CSR to other C H genes. Primary germ-line C H transcripts are processed to a form in which the I exon is spliced to the C H exon to yield ''sterile'' transcripts that do not encode a protein. Therefore, it is likely that germ-line C H transcription and͞or transcripts play a direct role in the CSR process, a notion strongly supported by gene-targeted mutation experiments (6) (7) (8) (9) (10) (11) (12) (13) (14) . Correspondingly, the elements that control germ-line transcription must be directly responsible for control of CSR.
Although germ-line C H gene promoters contain consensus sequences that are responsive to signaling pathways activated by specific lymphokines, their properly regulated expression appears to require sequences beyond the proximal promoters (reviewed in ref. 3) . One candidate was the intronic IgH enhancer region (iE); however, various studies suggest that the major function of this region may be to promote germ-line transcription through S, as opposed to regulating downstream I region promoters (10) (11) (12) (13) 15) . Moreover, the expression of switched V(D)J-C H transcripts in cell lines in the absence of iE suggested the existence of additional regulatory sequences (16, 17) . The initial candidate for such a regulatory sequence was an enhancer sequence discovered about 15 kb downstream of C␣, referred to as the 3Ј C␣E (18) (19) (20) . However, more recent studies showed that the 3Ј C␣ region comprises a series of DNase-hypersensitive sites͞ enhancers spread over approximately 40 kb including from 5Ј to 3Ј: HS3a, HS1,2 (the original 3Ј C␣E), HS3b, and HS4 (21, 22) . Cell line transfection studies suggested that combinations of the HS3a, HS1,2, HS3b, and HS4 elements may have locus control region (LCR)-like properties (21, 23) .
It has been suggested that sequences in the 3Ј IgH region may function as a long-range control region for regulation of CSR (24, 25) by regulating certain germ-line C H promoters in the context of B cell activation (24) . To further elucidate this putative regulatory region, we previously generated mice in which HS3a or HS1,2 was either deleted or replaced with a PGK-neo r cassette (24, 25) . None of these mutations had a measurable effect on V(D)J recombination, and none severely
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PNAS is available online at www.pnas.org. impaired in vitro activation of mutant B cells to secrete IgM, IgG1, or IgA. The deletion mutations also had little or no effect on CSR to any C H gene. However, mutant B cells with the PGK-neo r insertions were severely deficient in their ability to switch to IgG2a, IgG2b, IgG3, and IgE after appropriate stimulation, and these defects correlated with corresponding defects in GT of and CSR to the affected C H genes (24, 25) . Therefore, the HS3a and HS1,2 replacement mutations inhibited CSR to different C H genes spread over 120 kb. Similar long-range inhibitory effects of such insertion͞replacement mutations also have been found in the context of targeted mutations of the ␤-globin LCR region (26) (27) (28) (29) and, although studied in less detail, in the context of targeted mutations of other genetic loci (30) (31) (32) (33) (34) (35) (36) (37) . The similarity of the HS3a and HS1,2 replacement mutation phenotypes, both of which were cis-acting, suggested that the inhibition of CSR resulted from effects of the inserted PGKneo r gene, potentially via competition of the inserted promoter for control elements in the putative 3Ј IgH CSR regulatory locus. These findings also led to the suggestion that CSR recombination could be regulated, at least in part, by the relative ability of various germ-line C H promoters, after activation, to compete for activities of this putative regulatory region (24, 25) . Here, we report studies designed to test postulates of such a 3Ј IgH locus regulatory model by examining the effects of insertion of the PGK-neo r gene at two sites within the C H locus on GT of and CSR to upstream and downstream C H genes.
MATERIALS AND METHODS
Generation of I␥2b and IgE C H Mutant Mice. We previously have described (10) the generation of embryonic stem (ES) cells homozygous for a mutation in which the PGK-neo r resistance gene was inserted in place of I␥2b sequences in the same transcriptional orientation as the endogenous unit (referred to as I␥2bN͞N cells) and ES cells homozygous for a mutation in which the PGK-neo r gene that replaces I␥2b sequences was deleted on both alleles (referred to as I␥2bϪ͞Ϫ cells). These homozygous mutant ES cells subsequently were assayed for effects of the mutations on CSR by the RAG-2-deficient blastocyst complementation as described previously (10, 24) . For these analyses, chimeras were assayed for serum Ig isotypes at 10-12 weeks of age. For all other experiments, chimeras were between 1 and 8 months in age. The IgEN͞N mice, homozygous for a mutation in which a PGK-neo r gene was inserted in the opposite transcriptional orientation as the endogenous C1-4 exons, have been described previously (38) . The germ-line IgE mutant mice were analyzed at 5-8 weeks. The general structure of the mutations analyzed is outlined in Fig. 1 .
Splenocyte Cultures. Single-cell suspensions of spleen cells were prepared as described previously (39) . Subsequently, cells were cultured and maintained at a concentration of 10 6 cells͞ml in RPMI 1640͞10% FCS medium [supplemented with 2-mercaptoethanol (50 mM), penicillin (100 units͞ml), streptomycin (100 g͞ml), and glutamine (2 mM ELISA Analysis. Supernatants from day 4 or 4.5 splenocyte cultures or sera were analyzed for the presence of different Ig isotypes by sandwich ELISA assay as previously described (14, 40) by using goat anti-mouse IgG2b, goat anti-mouse IgG3, goat anti-mouse IgG1, goat anti-mouse IgM, goat anti-mouse IgA coating (SBA), anti-IgE (R35-72) coating (PharMingen), alkaline phosphatase-labeled anti-mouse IgG2b (R12-3) (PharMingen), anti-mouse IgG3, anti-mouse IgG1, anti-mouse IgM, anti-mouse IgA (SBA) revealing, biotin labeled anti-IgE (R35-92) (PharMingen) revealing, and alkaline phosphataselabeled streptavidin (SBA). Standards used were IgG2a, IgG3, IgG1, IgG2b, IgA (SBA), IgM (Zymed), and IgE (IgE-3) (PharMingen). Cultures were established in triplicate for each assay. Sensitivity of the assays ranged from 10 to 20 ng͞ml.
Northern Blot Analysis. RNA was prepared using Trizol reagent (GIBCO͞BRL) as per the instructions of the manufacturer. For Northern blot analyses (41) , approximately 10-15 g of total RNA was electrophoresed through a 1% agarose gel, transferred to Zetaprobe membrane (Bio-Rad), and assayed for hybridization with probes labeled by random hexamer priming with [␣-32 P]dCTP. The C␥2b probe is an Ϸ300-bp SacI-SacI genomic fragment of the C H 3 region of C␥2b. The mb-1 probe was generated from a full-length 900-bp cDNA. The C␥3 probe was a BamHI 6-kb genomic fragment spanning most of C␥3 and Ϸ4.5 kb 3Ј of C␥3 (42) . The C probe was an Ϸ2.5-kb SacI genomic fragment spanning all C exons. The C probe is a 900-bp XbaI-BamHI genomic fragment spanning 5Ј of C. The I␥2b probe is a HindIII-XhoI 500-bp genomic fragment from the plasmid SKA (gift of S. Li, Columbia University).
PCR Amplification of Germ-Line Transcripts. Total RNA was isolated from 1 ϫ 10 7 day 2 LPS (for ␥3) or LPS ϩ IL-4 (for I) stimulated splenocytes using the Trizol reagent (GIBCO͞BRL) as per the manufacturer's instructions. We generated cDNA by using Superscript (GIBCO͞BRL) according to the manufacturer's instructions. Germ-line I and I␥3 transcripts were amplified as described previously (25) . The cDNA samples were diluted into mouse genomic DNA to keep a consistent amount of 100 ng total DNA per reaction. Probes used for detection of PCR products were a BamHI 6-kb C␥3 genomic fragment (42), a 1.3-kb genomic PstI I fragment, and a mb-1 probe generated from a full-length 900-bp cDNA.
RESULTS

Insertion of PGK-neo
r Genes into the I␥2b Locus Inhibits CSR to the C␥3 Gene. We employed the RAG-2-deficient blastocyst complementation method to generate chimeric mice containing B lymphocytes derived from I␥2b mutant ES cells as described previously (10) . Mutant ES cells assayed contained targeted mutations in which most of the I␥2b exon was either deleted on both chromosomes (I␥2bϪ͞Ϫ) or replaced with a PGK-neo r gene in the same transcriptional orientation as the endogenous locus on one (I␥2bϩ͞N) or both (I␥2bNN) chromosomes (ref. 10; Fig. 1 ). Previously, we have shown that homozygous insertion of a PGK-neo r gene in place of HS3a (HS3aN͞N) or HS1,2 (HS1,2N͞N) inhibits generation of serum IgG3 and IgG2a (refs. 24 and 25; Fig. 1 ). Likewise, ELISA measurement of serum Ig levels demonstrated severely reduced levels of IgG3 (30-to 50-fold) in I␥2bN͞N chimeras versus I␥2bϩ͞N or wild-type (wt) mice (Fig. 2 Upper) . However, the serum levels of all other measured IgH isotypes, including IgG2a, were similar in I␥2bN͞N chimeras as compared with those of controls (Fig. 2) .
We previously have observed CSR defects to a large set of C H genes, including C␥3, C␥2b, C␥2a, and C in HS3aN͞N or HS1,2N͞N B cells assayed in vitro (24, 25) . As expected (10), LPS-stimulated I␥2bϪ͞Ϫ splenic B cells failed to switch to IgG2b, whereas I␥2bN͞N splenic B cells switched to IgG2b at approximately wt levels (Fig. 2) . To determine whether the inserted PGK-neo r gene affected CSR to other C H genes, B cells from I␥2bN͞N, I␥2bϩ͞N, I␥2Ϫ͞Ϫ, and wt mice were stimulated in culture for 4 or 5 days with either LPS (for CSR to C␥3 and C␥2b, LPS plus IL-4 (for CSR to C␥1 and C), LPS plus interferon ␥ (for CSR to C␥2a), or LPS plus transforming growth factor ␤ (for CSR to C␣) and then assayed by various methods for CSR. Class switching to all IgH isotypes other than IgG2b was similar to that of wt for cultured I␥2bϪ͞Ϫ B cells as measured by FACS for surface Ig isotype expression and by ELISA for supernatant Ig levels in the cultures (ref. 10; Fig. 2 Lower, and data not shown). For appropriately stimulated I␥2bN͞N B cells, surface expression and secretion of IgG2a, IgE, and IgA, isotypes encoded by C H genes downstream of the insertion were at levels comparable to those of wt and I␥2bϩ͞N B cells, both as assayed by surface expression (not shown) and by supernatant secretion (Fig. 2) . However, production of IgG3 (an isotype encoded by a C H gene 5Ј to the PGK-neo r insertion) was reduced severely in I␥2bN͞N B cells after in vitro stimulation with LPS ( Fig. 2 and data not shown) . In contrast, production of IgG1 was only partially reduced and IgA was not greatly affected, similar to our observations with HS3aN͞N and HS1,2 N͞N B cells (refs. 24 and 25; Figs. 1  and 2) . Deficient CSR to Upstream C H Genes in IgEN͞N Mice. To determine whether PGK-neo r insertions at other locations or in the reverse orientation within the C H locus resulted in CSR defects, we assayed mice homozygous for a germ-line mutation in which exons 1-4 of the C gene were replaced with a PGK-neo r gene inserted in the opposite transcriptional orientation as the endogenous locus (IgEN͞N) (ref. 38; Fig. 1 ). These mice are not capable of producing IgE and previously had been reported to have normal serum IgG levels (38) . However, in those studies, serum IgG levels were assayed with pan-IgG antibodies, which would have missed specific deficiencies in IgG3, IgG2b, and IgG2a (38) . Analysis of the serum isotype levels of IgEN͞N mice by ELISA revealed that these mutant mice had class-switch defects reminiscent of HS3aN͞N or HS1,2N͞N mice (Fig. 2 Upper) . Thus, serum IgG3, IgG2b, and IgG2a levels were reduced significantly (from 10-to 100-fold), whereas IgM, IgG1, and IgA levels were comparable to normal. Likewise, cultured B cells from IgEN͞N displayed class-switch defects essentially identical to those that we have observed previously for HS3aN͞N and HS1,2N͞N B cells (Fig.  2 Lower) . Thus, production of IgG3, IgG2a, and IgG2b (and IgE) was reduced severely after activation by appropriate stimuli, whereas production of IgG1 was somewhat reduced and that of IgA was not affected substantially (Fig. 2) .
CSR Defects in I␥2b and C PGK-neo r Insertion Mutant B Cells Correlate with Corresponding Defects in Germ-Line C H Gene Transcription.
To further elucidate the mechanisms by which class switching was blocked in I␥2bN͞N and IgEN͞N B cells, we employed Northern blotting to assay expression of C H transcripts in cultured mutant and control B cells after 2 or 5 days of the various stimulations. Most of the Northern analyses employed probes (C H probes) that would detect both germ-line or mature [i.e., V(D)J containing] transcripts. Both C and mb-1 probes were used to standardize the amount of B cell RNA assayed by Northern blotting (Fig. 3A) . As detected by Northern blotting, the accumulation of C␥3-hybridizing transcripts were inhibited severely after LPS treatment of I␥2bN͞N B cells, whereas the levels of other tested C H -hybridizing transcripts in the variously treated cells were not substantially different from those of controls (Fig. 3A) . On the other hand, levels of both C␥3-and C␥2b-hybridizing transcripts were markedly reduced in LPS-stimulated IgEN͞N B cells as compared with controls (Fig. 3A) .
To more specifically test the effect of the mutations on accumulation of germ-line transcripts, we assayed Northern blots for hybridization to an I␥2b probe and also assayed for 
DISCUSSION
Inhibition of CSR by Insertion of PGK-neo
r Genes into the Ig C H Locus. We previously showed that mutations just 3Ј of the IgH locus, in which HS3a and HS1,2 were replaced with a PGK-neo r gene, impaired GT of and CSR to a subset of C H genes in cultured B lymphocytes, including C␥3, C␥2a, C␥2b, and C (24, 25) . These findings suggested a model in which insertion of the PGK-neo r gene interfered with the activities of a long-range CSR regulatory region that controls relative expression of certain C H promoters and, as a result, CSR (3, 24) . In support of this hypothesis, we now show that cultured B cells harboring a PGK-neo r cassette in place of I␥2b sequences are impaired in GT of and CSR to the upstream C␥3 gene, but not to the downstream C␥2a and C genes. Moreover, we show further that B cells in which the C exons have been replaced with the PGK-neo r cassette, in the opposite transcriptional orientation to that of the other insertion mutations, are impaired in GT of and CSR to the upstream C␥3, C␥2b, and C␥2a genes. Therefore, the observed inhibitory effects are not strictly dependent on the transcriptional orientation of the PGK-neo r gene.
Together, our findings support the existence of a long-range 3Ј IgH regulatory region required for GT of and CSR to multiple C H genes and suggest that PGK-neo r cassette insertion into the locus short circuits the ability of this region to facilitate GT of dependent C H genes upstream, but not downstream, of the insertion site. Of note, replacement of the E͞MAR region (11) or a portion of the C coding sequence (43) with PGK-neo r did not appear to substantially affect switching to tested isotypes encoded by downstream C H genes, even though these insertions were physically more proximal to   FIG. 1 . Insertion of the PGK-neo r gene in the IgH locus disrupts class switching upstream of the insertion. Summary of the effects on CSR in gene-targeting experiments within the IgH locus using the PGK-neo r gene as a selectable marker. I␥2b and IgE CH1-4 summarize experiments presented here, and HS1,2 and HS3a summarize previously published studies (24, 25) . The effect on CSR is noted as inhibition (downward-pointing arrow), partial inhibition (ϩ͞Ϫ), or CSR levels comparable to wt controls (ϩ). Transcripts and transcriptional orientation are represented by horizontal arrows. ND, not determined. I, I exon; S, switch region; C, constant region genes for corresponding isotype. I␥3 than the HS1,2 insertion-further supporting the notion that inhibition may be dependent on insertion of the PGK-neo r gene between the affected I region promoter and a 3Ј regulatory region. The overall findings regarding polarized effects of inserted PGK-neo r genes on CSR supports the existence of a CSR regulatory locus 3Ј of the IgH locus that could comprise the four known HS sites and͞or elements that are yet to be determined. Because deletion of the HS3a or HS1,2 elements per se had no major effect on CSR, these elements must either be redundant in function for this regulatory region or, more likely, critical regulatory elements lie downstream of HS1,2.
PGK-neo r Insertion Mutations Affect Only a Subset of C H Genes. Neither the HS3a nor the HS1,2 PGK-neo r insertion mutations substantially affected switching to the C␣ gene either in vivo or in cultured B cells, suggesting that C␣ expression may not be dependent on the 3Ј regulatory sequences affected by these mutations (24, 25) . Because our currently analyzed mutations did not dramatically affect switching to IgA, but also were upstream to the C␣ gene, they offer no additional insights. Similarly, switching to IgG1 was only partially affected by the various analyzed mutations, consistent with the notion that GT of the C␥1 gene may be influenced by elements that are, at least partially, independent of the putative 3Ј IgH sequences (ref. 24 and 25; this study). Of note, we usually can detect at least low-level expression of even the most severely inhibited IgH isotypes in the serum of I␥2bN͞N chimeras or of IgEN͞N, HS3aNN, and HS1,2N͞N mice, suggesting that there may be alternative pathways for switching to some isotypes (e.g., IgG2b; refs. 24 and 25) or that the very low level switching observed in vitro is sufficient to allow accumulation of switched cells and͞or observed serum Ig isotypes. In this regard, our detection of C␥3-hybridizing transcripts in day 5 LPS-treated I␥2bN͞N cells, but not I␥3-C␥3 transcripts by RT-PCR assay of day 2 treated cells ( Fig. 3) , may ref lect the low-level generation of IgG3-producing B cells followed by accumulation of transcripts during culture.
What Aspect of the Inserted PGK-neo r Gene Causes the Inhibitory Effects? The ␤-globin LCR has been speculated to regulate differential ␤-globin locus gene expression via a promoter-competition mechanism (44) (45) (46) , although other interpretations remain possible (44, (46) (47) (48) . Likewise, one interpretation of our findings that PGK-neo r insertion into the downstream portions of the IgH locus interferes with transcription from upstream I exon promoters is that PGK-neo r competes with affected I region promoters for interactions with elements of the putative 3Ј IgH regulatory region necessary for transcriptional activation. Comparable inhibitory effects have been described with respect to insertion of transcribed marker genes into the ␤-globin LCR, which is reminiscent in organization to the 3Ј IgH enhancer region (21, 26, 27, 29, 49) . Consistent with this model, insertion of the PGK-neo r gene in the IgH locus renders the neo r gene LPSinducible (10, 25) . However, although these findings are consistent with promoter-competition mechanisms to explain the negative effects of the PGK-neo r cassette, they do not eliminate other conceivable long-range mechanisms. For example, rather than strict promoter competition, the PGK promoter could alter local chromatin structure in a manner that prevents access and interaction of the 3Ј IgH regulatory region with upstream I exon promoters (47) .
Whatever the absolute mechanism, the many similarities between the overall organization of the ␤-globin LCR and the 3Ј IgH region suggest that these two loci have evolved similar strategies to regulate differential gene expression. However, it has not been proven formally in any system that the effects of the inserted PGK-neo r cassette are mediated by its promoter; nor has it been shown exactly how promoters might function in such a ''competition.'' Negative effects of PGK-neo r gene insertion have been observed in several loci; it is conceivable that not all mechanisms of inhibition are the same (discussed in ref. 25) . Several additional mechanisms besides promoterbased mechanisms have been considered to potentially explain inhibitory effects of the PGK-neo r cassette inserted into the Ig locus (33, 34, 50, 51) . However, given the great distance and polarity of the effects of the PGK-neo r cassette in the IgH locus, a promoter-based mechanism seems most likely in this case. Further support for this notion comes from the recent finding that replacement of the I␣ exon with a PGKhypoxanthine phosphoribosyltransferase minigene inhibits CSR to several upstream C H genes (13) . Of note, not all promoters appear to have such strongly negative effects as PGK. For example, insertion of a neo r selectable marker driven by the polyoma enhancer͞herpes simplex virus thymidine kinase promoter did not lead to obvious inhibition of CSR to upstream C H genes, although orientation and insertion site remain a variable in these experiments (6, 7, 14, 52). Finally, promoters other than PGK may cause such negative effects, (26, 27) .
Model for Control of IgH CSR. Our current findings are consistent with our earlier hypothesis that promoter ''competition'' may be a general mechanism employed for modulating GT and CSR activity in the IgH locus (24, 25) . In this context, we propose that transcription from, at least a subset of, I region promoters is based on ability of the local I region promoter to ''interact'' with the putative 3Ј regulatory region to achieve transcription. In the context of such a model, LPS treatment, for example, would lead to activation of the local I␥2b and I␥3 promoters, which, via interaction with the 3Ј regulatory region, would initiate transcription and lead to CSR. On the other hand, addition of IL-4 along with LPS would activate the local I␥1 and I promoters, which, based on this model, would out-compete the I␥2b or I␥3 promoters for 3Ј regulatory regions, perhaps because of promoter strength, the more 3Ј position, or both. In any case, such competition would lead to I␥1 or I transcription and extinguish I␥2b and I␥3 transcription (via competition). Of potential relevance, recent studies of a transgenic ␤-globin locus showed that a second ␤-globin gene competed more efficiently with other genes to which it was LCR-proximal (45) , supporting the looping model of LCR function in which one gene interacts with the LCR at a time (discussed in ref. 44 ). This general model for regulation of germ-line C H promoter expression could extend to other C H genes and other activation͞lymphokine pathways, although some C H genes clearly may be activated by independent mechanisms, at least under some conditions. Probes used were (in this order) C␥2b CH3 region, C␥3, mb-1, C, and C. Transcript sizes for productive (p) and germ-line (g) C are 2 kb; for C␥3 transcript, sizes are 3.3 membrane (m) and 1.9 secreted (s), where p and g transcripts are a similar size. P and g C␥2b transcripts are 3.6 (m) and 1.7 (s) (53) . P and g ␥3 transcripts are 3.3 (m) and 1.9 (s) (54) , the g transcript is 1.7, and the p is 2.3 (14) . 129, Wild type. One representative experiment of three is shown. (B) RT-PCR for ␥3 (LPS-stimulated) and (LPS ϩ IL-4-stimulated) germ-line transcripts. cDNA derived from cells stimulated for 2 days in culture was diluted 1:1, 1:5, and 1:25 for all samples. Mb-1 RT-PCR was used as a control for amount of cDNA per reaction. Wild-type controls are indicated as WT. One representative experiment of three is shown.
